Clinical trial
Celecoxib in Treating Patients With Progressive Metastatic Differentiated…
NCT00061906 · Ohio State University Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00061906 |
|---|---|
| Title | Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer |
| Official title | Phase II Study Of Celecoxib In Metastatic Differentiated Thyroid Carcinoma |
| Lead sponsor | Ohio State University Comprehensive Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | celecoxib |
| Enrollment | 25 |
| Start date | Jan 1, 2003 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Jun 6, 2003 |
| Last update posted | Feb 11, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: